Mackenzie Financial’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,845
Closed -$962K 1699
2025
Q3
$962K Sell
20,845
-989
-5% -$52.8K ﹤0.01% 1076
2025
Q2
$1.15M Buy
+21,834
New +$1.15M ﹤0.01% 979
2023
Q1
Sell
-9,773
Closed -$1.3M 1533
2022
Q4
$1.3M Buy
+9,773
New +$1.19M ﹤0.01% 741
2022
Q1
Sell
-1,463
Closed -$261K 1426
2021
Q4
$261K Buy
+1,463
New +$261K ﹤0.01% 1210
2021
Q2
Sell
-1,803
Closed -$270K 1242
2021
Q1
$270K Buy
+1,803
New +$219K ﹤0.01% 1030

Other funds holding CNXC

Mackenzie Financial's CNXC Position: Q4 2025 in Review

Mackenzie Financial sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 20,845 shares — an estimated $962K sold.

Mackenzie Financial first reported a position in CNXC in Q1 2021 and held it in 5 quarters. The position peaked at $1.3M in Q4 2022. 337 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • Mackenzie Financial reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • Mackenzie Financial sold 20,845 Concentrix shares in Q4 2025, an estimated $962K.
  • Mackenzie Financial first reported a position in Concentrix in Q1 2021 and held it in 5 quarters.
  • Mackenzie Financial's Concentrix position peaked at $1.3M in Q4 2022.
  • 337 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on Mackenzie Financial's 13F filing for Q4 2025, filed 18 Feb 2026.